Expression and Activation of Caspase-3 and Neuroprotective Effects of Z-DEVD. Fmk in Cerebral Ischemia Reperfusion Injury

LI Xin-gang
DOI: https://doi.org/10.3321/j.issn:1001-9030.2008.08.010
2008-01-01
Abstract:Objective To evaluate the effects of Caspase-3 activation and neuroprotection of ZDEVD. fmk in cerebral ischemia repeffusion induced neuronal cell death. Methods Focal cerebral ischemia C57L mice model was established by middle cerebral occlusion (MACo) method. Caspase-3 activity and activation was determined by enzyme activity assay and Western blot at different time points after completion of ischemia repeffusion. Caspase-3 activation ,infarct volume and neurological score were measured and evaluated after intraventricular injection of Z-DEVD. fmk. Results (1) Caspase-3 activation occurred immediately at 3 h after ischemia reperfusion ,gradually increased and reached the peak at 12-24 h.(2) Caspase-3 was significantly activated at 24 h after ischemia reperfusion, and its activation was increased by 7.6 times in comparison with the sham controls ( P < 0.01 ). ( 3 ) As compared with DMSA control group,the Caspase-3 Caspase-3 activation was decreased by 2.5 times in Z-DEVD. fmk treatment group ( P < 0.01 ). (4) Infarct volume in Z-DEVD. fmk treatment group [ (40.9 ± 4.1 ) mm3 ] was significantly less than that in DMSO control group [ (21.6 ± 4.9) mm3, P < 0.01 ]. Neurological score in ZDEVD. fmk treatment group (0.8 ± 0.4 ) was also significantly less than that in DMSO control group (2.2 ±0.3 ,P < 0.05). Conclusion Caspase-3 activation plays critical role in neuronal cell death induced by cerebral ischemeia reperfusion. Caspase-3 activation was significantly inhibited by Z-DEVD. fmk via intraventricular injection. Z-DEVD. fmk has dramatic neuroprotective effect in cerebral ischemeia reperfusion injury. It provides insights into the mechanism of events involved in ischmeia reperfusion injury.
What problem does this paper attempt to address?